Evidence map›Paper›PMID 26171733›Full record

Trial reportTelemedicine journal and e-health : the official journal of the American Telemedicine Association2015

Predictors of Utilization of a Novel Smoking Cessation Smartphone App.

Emily Y Zeng, Roger Vilardaga, Jaimee L Heffner, Kristin E Mull, Jonathan B Bricker

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Telemedicine journal and e-health : the official journal of the American Telemedicine Association, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. NoFumo+: A Clinical Trial of an mHealth for Smoking Cessation with Hospitalized Patients.International journal of environmental research and public health · 2021
    Trial
  7. Pilot Randomized Controlled Trial of a Novel Smoking Cessation App Designed for Individuals With Co-Occurring Tobacco Use Disorder and Serious Mental Illness.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2020
    Trial
  8. Trial
  9. Feasibility of a Smartphone-Based Tobacco Treatment for HIV-Infected Smokers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2020
    Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Emily Y Zeng1 Department of Psychology, University of Washington , Seattle, Washington.
Roger Vilardaga2 Division of Public Health Sciences, Fred Hutchinson Cancer Research Center , Seattle, Washington.
Jaimee L Heffner2 Division of Public Health Sciences, Fred Hutchinson Cancer Research Center , Seattle, Washington.
Kristin E Mull2 Division of Public Health Sciences, Fred Hutchinson Cancer Research Center , Seattle, Washington.
Jonathan B Bricker1 Department of Psychology, University of Washington , Seattle, Washington.

Funding

Randomized Trial of Web-Delivered Acceptance Therapy for Smoking CessationR01CA166646 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BRICKER, JONATHAN B · 2013 to 2017
$3.4M
Acceptance & Commitment Therapy for Smoking CessationR01CA151251 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BRICKER, JONATHAN B · 2010 to 2014
$3.0M
Targeted Intervention for Bipolar SmokersK23DA026517 · NIDA · UNIVERSITY OF CINCINNATI · PI HEFFNER, JAIMEE · 2009 to 2013
$654k
Innovative Smartphone Application for Quitting Smoking among Seriously Mentally IK99DA037276 · NIDA · UNIVERSITY OF WASHINGTON · PI VILARDAGA, ROGER · 2014 to 2015
$344k
NCI NIH HHS R01 CA151251NCI NIH HHS R01CA151251NCI NIH HHS R01 CA166646NCI NIH HHS R01CA166646NIDA NIH HHS 1K99DA037276-01NIDA NIH HHS K23 DA026517NIDA NIH HHS K23DA026517NIDA NIH HHS K99 DA037276
6 · The paper itself

Abstract

backgroundUnderstanding the characteristics of high and low utilizers of smartphone applications (apps) for smoking cessation would inform development of more engaging and effective apps, yet no studies to date have addressed this critical question. Informed by prior research on predictors of cessation Web site utilization, this study examines the degree to which baseline demographic factors (gender, age, and education), smoking-related factors (smoking level and friends' smoking), and psychological factors (depression and anxiety) are predictive of utilization of a smartphone app for smoking cessation called SmartQuit. MATERIALS AND

methodsData came from 98 participants randomized to SmartQuit as part of a pilot trial from March to May 2013. We used negative binomial count regressions to examine the relationship between user characteristics and utilization of the app over an 8-week treatment period.

resultsLower education (risk ratio [RR]=0.492; p=0.021), heavier smoking (RR=0.613; p=0.033), and depression (RR=0.958; p=0.017) prospectively predicted lower app utilization. Women (RR=0.320; p=0.022), those with lower education (RR=0.491; p=0.013), and heavier smokers (RR=0.418; p=0.039) had lower utilization of app features known to predict smoking cessation.

conclusionsMany of the predictors of utilization of smoking cessation apps are the same as those of cessation Web sites. App-delivered smoking cessation treatment effectiveness could be enhanced by focusing on increasing engagement of women, those with lower education, heavy smokers, and those with current depressive symptoms.

Indexed as

SmartphoneSmoking CessationFemaleHumansMaleMobile ApplicationsYoung Adultapplicationsmobile healthnicotinesmartphonesmoking cessationtobaccoutilization

Identifiers

PMID26171733
PMCPMC4776539

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.